Elevation Oncology, Inc.
General ticker "ELEV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $65.8M (TTM average)
Elevation Oncology, Inc. does not follow the US Stock Market performance with the rate: -11.4%.
Estimated limits based on current volatility of 1.6%: low 0.37$, high 0.38$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.37$, 1.55$]
- 2025-12-31 to 2026-12-31 estimated range: [0.41$, 1.53$]
Financial Metrics affecting the ELEV estimates:
- Negative: Non-GAAP EPS, $ of -0.81 <= 0.05
- Negative: Operating cash flow per share per price, % of -50.37 <= 1.99
- Negative: Operating profit margin, % of -100 <= 0.04
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
- Negative: 42.99 < Shareholder equity ratio, % of 62.77 <= 63.58
- Negative: Industry earnings per price (median), % of -24.73 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -20.97 <= 2.94
Short-term ELEV quotes
Long-term ELEV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $94.55MM | $45.45MM | $44.70MM |
| Operating Income | $-94.55MM | $-45.45MM | $-44.70MM |
| Non-Operating Income | $-0.51MM | $-0.23MM | $0.26MM |
| R&D Expense | $78.72MM | $25.43MM | $28.60MM |
| Income(Loss) | $-95.06MM | $-45.67MM | $-44.44MM |
| Taxes | $0.03MM | $0.03MM | $0.04MM |
| Profit(Loss)* | $-95.08MM | $-45.70MM | $-44.48MM |
| Stockholders Equity | $49.03MM | $54.81MM | $60.02MM |
| Assets | $94.16MM | $89.09MM | $95.63MM |
| Operating Cash Flow | $-85.48MM | $-56.18MM | $-36.36MM |
| Capital expenditure | $0.09MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-44.40MM | $11.54MM | $-8.37MM |
| Financing Cash Flow | $29.51MM | $47.98MM | $44.94MM |
| Earnings Per Share** | $-4.09 | $-1.34 | $-0.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.